Gene expressions of antiinflammatory mediators in THR retrieved interfacial membranes

References

• Bigler C F, Norris D A, Weston W L, Arend W P. Interleukin‐1 receptor antagonist production by human keratinocytes. J Invest Dermatol 1992; 98(1)38–44
   PubMed Web of Science ®Google Scholar
• Butch A W, Chung G ‐H, Hoffmann J W, Nahm M H. Cytokine expression by germinal center cells. J Immunol 1993; 150(1)39–47
   PubMed Web of Science ®Google Scholar
• Chemoff A E, Granowitz E V, Shapiro L, Vannier E, Lonnemann G, Angel J B, Kennedy J S, Rabson A R, Wolff S M, Dinarello C A. A randomized, controlled trial of IL‐10 in humans. J Immunol 1995; 154(10)5492–9
   PubMed Web of Science ®Google Scholar
• Chomarat P, Vannier E, Dechanet J, Rissoan M C, Banchereau J, Dinarello C A, Miossec P. Balance of IL‐1 receptor antago‐nist/IL‐18 in rheumatoid synovium and its regulation by IL‐4 and IL‐10. J Immunol 1995; 154(3)1432–9
   PubMed Web of Science ®Google Scholar
• De Wall Malefyt R, Haanen J, Spits H, Roncarolo M ‐G, te Velde A, Figdor C, Johnson K, Kastelein R, Yssel H, de Vries JE. Interleukin 10 (IL‐10) strongly reduces antigen‐specific human T cell proliferation by diminishing the antigen‐presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med 1991a; 174(4)915–24
   PubMed Web of Science ®Google Scholar
• De Wall Malefyt R, Abrams J, Bennett B, Figdor C G, de Vries J E. Interleukin 10 (IL‐10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL‐10 produced by monocytes. J Exp Med 1991b; 174(5)1209–20
   PubMed Web of Science ®Google Scholar
• Dripps D J, Brandhuber B J, Thompson R C, Eisenberg S P. In‐terleukin‐1 (IL‐1) receptor antagonist binds to the 80‐kDa IL‐1 receptor but does not initiate IL‐1 signal transduction. J Biol Chem 1991; 266(16)10331–6
   PubMed Web of Science ®Google Scholar
• Esnault S, Benbernou N, Lavaud F, Shin H C, Potron G, Guen‐nounou M. Differential spontaneous expression of mRNA for IL‐4, IL‐10, IL‐13, IL‐2 and interferon‐gamma (IFN‐y) in peripheral blood mononuclear cells (PBMC) from atopic patients. Clin Exp Immunol 1996; 103(1)111–8
   PubMed Web of Science ®Google Scholar
• Firestein G S, Boyle D L, Yu C, Paine M M, Whisenand T D, Zvaifler N J, Arend W P. Synovial interleukin‐1 receptor antagonist and interleukin‐1 balance in rheumatoid arthritis. Arthritis Rheum 1994; 37(5)644–52
   PubMedGoogle Scholar
• Haskill S, Martin G, van Le L, Morris J, Pease A, Bigler C F, Jaffe G J, Hammerberg C, Sporn S A, Fong S, Arend W P. cDNA cloning of an intracellular form of the human interleukin 1 receptor antagonist associated with epithelium. Proc Natl Acad Sci USA 1991; 88(9)3681–5
   PubMed Web of Science ®Google Scholar
• Heuer M, Aust G, Ode‐Hakim S, Scherbaum W A. Different cytokine mRNA profiles in Graves' disease, Hashimoto's thyroiditis, and nonautoimmue‐thyroid disorders determined by quantitative reverse transcriptase polymerase chain reaction (RT‐PCR). Thyroid 1996; 6(2)97–106
   PubMed Web of Science ®Google Scholar
• Horowitz S M, Doty S B, Lane J M, Burstain A H. Studies of the mechanism by which the mechanical failure of polymethylmethacrylate leads to bone resorption. J Bone Joint Surg (Am) 1993; 75(6)802–13
   PubMed Web of Science ®Google Scholar
• Isomäki P, Luukkainen R, Saario R, Toivanen P, Punnonen J. Interleukin‐10 functions as an antiinflammatory cytokine in rheumatoid synovium. Arthritis Rheum 1996; 39(3)386–95
   PubMed Web of Science ®Google Scholar
• Jiranek W A, Machado M, Jasty M, Jevsevar D, Wolfe H J, Goldring S R, Goldberg M J, Harris W H. Production of cytokines around loosened cemented acetabular components. Analysis with immunohistochemical techniques and in situ hybridization. J Bone Joint Surg (Am) 1993; 75(6)863–79
   PubMed Web of Science ®Google Scholar
• Kasama T, Strieter R M, Lukacs N W, Lincoln P M, Burdick M D, Kumkel S L. Interleukin‐10 expression and chemokine regulation during the evolution of murine type II collagen‐induced arthritis. J Clin Invest 1995; 95(6)2868–76
   PubMed Web of Science ®Google Scholar
• Konttinen Y T, Waris V, Xu J ‐W, Jiranek W A, Sorsa T, Virtanen I, Santavirta S. Transforming growth factor‐βl and 2 in the syn‐ovial‐like membrane between implant and bone in loosening of total hip arthroplasty. J Rheumatol 1997a; 24(4)694–701
   PubMed Web of Science ®Google Scholar
• Konttinen Y T, Xu J W, Pätiälä H, Imai S, Waris V, Li T F, Goodman S B, Nordsletten L, Santavirta S. Cytokines in aseptic loosening of total hip replacement. Current Orthop 1997b; 11: 40–7
   Google Scholar
• Krzesicki R F, Hatfield C A, Bienkowski M J, McGuire J C, Win‐terrowd G E, Chapman D L, Berger A E, McEwan R N, Carter D B, Chosay J G, Tracey D E, Chin J E. Regulation of expression of IL‐1 receptor antagonist protein in human synovial and dermal fibroblasts. J Immunol 1993; 150(9)4008–18
   PubMed Web of Science ®Google Scholar
• McMahan C J, Slack J L, Mosley B, Cosman D, Lupton S D, Brunton L L, Grubin C E, Wignall J M, Jenkins N A, Brannan C I, Copeland N G, Huebner K, Croce C M, Cannizzarro L A, Benjamin D, Dower S K, Spriggs M K, Sims J E. A novel IL‐1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types. EMBO J 1991; 10(10)2821–32
   PubMed Web of Science ®Google Scholar
• Mulheron G W, Bossert N L, Lapp J A, Walmer D K, Schomberg D W. Human granulosa‐luteal and cumulus cells express transforming growth factors‐beta type 1 and type. 2 mRNA. J Clin Endocrinol Metab 1992; 74(2)458–60
   PubMed Web of Science ®Google Scholar
• Rott O, Fleischer B, Cash E. Interleukin‐10 prevents experimental allergic encephalomyelitis in rats. Eur J Immunol 1994; 24(6)1434–40
   PubMed Web of Science ®Google Scholar
• Sadouk M, Pelletier J ‐P, Tardif G, Kiansa K, Cloutier J ‐M, Mar‐tell‐Pelletier J. Human synovial fibroblasts coexpress IL‐1 receptor type I and type II mRNA. The increased level of the IL‐1 receptor in osteoarthritic cells is related to an increased level of the type I receptor. Lab Invest 1995; 73(3)347–55
   PubMed Web of Science ®Google Scholar
• Sims J E, Acres R B, Grubin C E, McMahan C J, Wingnall J M, March C J, Dower S K. Cloning the interleukin 1 receptor from human T cells. Proc Natl Acad Sci USA 1989; 86(22)8946–50
   PubMed Web of Science ®Google Scholar
• Sims J E, Gayle M A, Slack J L, Alderson M R, Bird T A, Giri J G, Colotta F, Re F, Mantovani A, Shanebeck K, Grabstein K H, Dower S K. Interleukin 1 signaling occurs exclusively with The type 1 receptor. Proc Natl Acad Sci USA 1993; 90(13)6155–9
   PubMed Web of Science ®Google Scholar
• Tang P ‐Z, Gannon M J, Andrew A, Miller D. Evidence for oestrogenic regulation of heat shock protein expression in human endometrium and steroid‐responsive cell lines. Eur J Endocrinol 1995; 133(5)598–605
   PubMed Web of Science ®Google Scholar
• Tucci M A, Baker R, Mohamed A, Tsao A K, Hughes J. Synovial tissues collected from rheumatoid patients undergoing total joint arthroplasty express markers for acute inflammation. Biomed Sci Instrum 1997; 34: 169–74
   PubMedGoogle Scholar
• Waris V, Xu J W, Nordsletten L, Sorsa T, Santavirta S, Konttinen Y T. Basic fibroblast growth factor (bFGF) in the synovial‐like membrane around loose total hip prostheses. Scand J Rheumatol 1996; 25(4)257–62
   PubMed Web of Science ®Google Scholar
• Weyand C M, Geisler A, Brack A, Bolander M E, Goronzy J J. Oligoclonal T‐cell proliferation and interferon‐gamma production in periprosthetic inflammation. Lab Invest 1998; 78(6)677–85
   PubMed Web of Science ®Google Scholar
• Implant wear: The future of total joint replacement, T M Wright, S B Goodman. American Academy of Orthopaedic Surgeons, Illinois 1996
   Google Scholar